| 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the … G Mancia, G De Backer, A Dominiczak, R Cifkova, R Fagard, G Germano, ... European heart journal 28 (12), 1462-1536, 2007 | 12320* | 2007 |
| 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with … FLJ Visseren, F Mach, YM Smulders, D Carballo, KC Koskinas, M Bäck, ... European heart journal 42 (34), 3227-3337, 2021 | 4916 | 2021 |
| EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries K Kotseva, D Wood, D De Bacquer, G De Backer, L Rydén, C Jennings, ... European journal of preventive cardiology 23 (6), 636-648, 2016 | 1331 | 2016 |
| Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of … MF Piepoli, U Corra, W Benzer, B Bjarnason-Wehrens, P Dendale, ... European Journal of Cardiovascular Prevention & Rehabilitation 17 (1), 1-17, 2010 | 1070 | 2010 |
| Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial SS Anand, J Bosch, JW Eikelboom, SJ Connolly, R Diaz, P Widimsky, ... The Lancet 391 (10117), 219-229, 2018 | 967 | 2018 |
| Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry K Kotseva, G De Backer, D De Bacquer, L Rydén, A Hoes, D Grobbee, ... European journal of preventive cardiology 26 (8), 824-835, 2019 | 869 | 2019 |
| European Society of Cardiology: cardiovascular disease statistics 2021 A Timmis, P Vardas, N Townsend, A Torbica, H Katus, D De Smedt, ... European heart journal 43 (8), 716-799, 2022 | 780* | 2022 |
| Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and … M Ambrosetti, A Abreu, U Corrà, CH Davos, D Hansen, I Frederix, ... European journal of preventive cardiology 28 (5), 460-495, 2021 | 771 | 2021 |
| Secondary prevention in the clinical management of patients with cardiovascular diseases. Core components, standards and outcome measures for referral and delivery: a policy … MF Piepoli, U Corrà, S Adamopoulos, W Benzer, B Bjarnason-Wehrens, ... European journal of preventive cardiology 21 (6), 664-681, 2014 | 739 | 2014 |
| EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study KK Ray, B Molemans, WM Schoonen, P Giovas, S Bray, G Kiru, J Murphy, ... European journal of preventive cardiology 28 (11), 1279-1289, 2021 | 633 | 2021 |
| Secondary prevention through cardiac rehabilitation: physical activity counselling and exercise training: key components of the position paper from the Cardiac Rehabilitation … EACPR Committee for Science Guidelines, U Corrà, MF Piepoli, F Carré, ... European heart journal 31 (16), 1967-1974, 2010 | 523 | 2010 |
| Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial SJ Connolly, JW Eikelboom, J Bosch, G Dagenais, L Dyal, F Lanas, ... The Lancet 391 (10117), 205-218, 2018 | 414 | 2018 |
| Management of dyslipidaemia in patients with coronary heart disease: results from the ESC-EORP EUROASPIRE V survey in 27 countries G De Backer, P Jankowski, K Kotseva, E Mirrakhimov, Ž Reiner, L Ryden, ... Atherosclerosis 285, 135-146, 2019 | 345 | 2019 |
| Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on Secondary and Primary … K Kotseva, D De Bacquer, G De Backer, L Rydén, C Jennings, V Gyberg, ... European journal of preventive cardiology 23 (18), 2007-2018, 2016 | 227 | 2016 |
| A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial D Vinereanu, RD Lopes, MC Bahit, D Xavier, J Jiang, HR Al-Khalidi, W He, ... The Lancet 390 (10104), 1737-1746, 2017 | 208 | 2017 |
| Cardiac rehabilitation availability and density around the globe K Turk-Adawi, M Supervia, F Lopez-Jimenez, E Pesah, R Ding, RR Britto, ... EClinicalMedicine 13, 31-45, 2019 | 205 | 2019 |
| Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) AJ Vallejo-Vaz, CAT Stevens, ARM Lyons, KI Dharmayat, T Freiberger, ... The Lancet 398 (10312), 1713-1725, 2021 | 200 | 2021 |
| Overview of the current status of familial hypercholesterolaemia care in over 60 countries-The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) AJ Vallejo-Vaz, M De Marco, CAT Stevens, A Akram, T Freiberger, ... Atherosclerosis 277, 234-255, 2018 | 198 | 2018 |
| Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the European Society of Cardiology EURObservational Research Programme … K Kotseva, G De Backer, D De Bacquer, L Rydén, A Hoes, D Grobbee, ... European journal of preventive cardiology 28 (4), 370-379, 2021 | 169 | 2021 |
| Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of … V Gyberg, D De Bacquer, G De Backer, C Jennings, K Kotseva, L Mellbin, ... Cardiovascular diabetology 14, 1-11, 2015 | 147 | 2015 |
